Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-08-26

Clinical Trial Update: Mycophenolate Mofetil (MMF) for Treatment of Chronic Graft-versus-host Disease (GVHD) [Phase 3]

View source ↗

Summary

Phase 3 trial of mycophenolate mofetil for chronic graft-versus-host disease in cancer patients was terminated, with results posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)

Snippet

Sponsor: Martin, Paul | Conditions: Cancer | Phase 3 | Status: TERMINATED | Results posted: 2009-08-26